Karolinska Development AB Namn-Aktier o.N.

Sector and Industry

Finance, Investment Services

Performance (1Y)

99.83%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.05 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Morgan Stanley239.26 Bil.106.12 Bil.17.39
+20.74 %
0.00
-
Goldman Sachs Group Inc221.89 Bil.111.88 Bil.17.13
+15.36 %
0.00
-
Citigroup Inc173.63 Bil.149.94 Bil.16.69
+8.33 %
0.00
-
Blackstone Inc.161.27 Bil.12.10 Bil.39.83
+4.26 %
0.00
-
Charles Schwab Corp.149.58 Bil.24.53 Bil.21.47
+42.84 %
0.00
-
Blackrock Inc.148.69 Bil.22.09 Bil.30.31
-16.40 %
0.00
-
UBS Group122.81 Bil.70.13 Bil.18.06
+46.64 %
0.00
-
KKR & Co. Inc.96.76 Bil.18.24 Bil.54.43
-26.12 %
0.00
-
Investor AB ser. B93.48 Bil.7.58 Bil.6.43
+43.87 %
0.00
-
Investor AB ser. A93.00 Bil.7.58 Bil.6.39
+43.87 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.0001 G0 Units
PRICE DETERMINATION TIME07/17/2026 / 09:56:49 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.010.0001
PREV. DAY'S PRICE0.0001 (07/16)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW0.0773 (10/07)0.0001 (02/25)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
0.000.00-0.05--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
85.34----
PRICE - BOOK RATIO
0.370.210.11--
PRICE - SALES RATIO
163.2344.3710.89--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A0M84G
ISIN
SE0002190926
SYMBOL
2I9
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
KAROLINSKA DEVELOP.AB
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYFinance, Investment Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-99.09 %
-99.23 %
0.00 %
-97.62 %
-99.83 %
-99.90 %
-
-99.39 %
HIGH0.010.020.020.040.080.12-0.05
LOW0.000.000.000.000.000.00-0.00

Dividende

pro Aktie
KAROLINSKA DEVELOP.AB does not deliver dividend information

Company profile

KDventures AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2003 and is headquartered in Solna, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.